<DOC>
	<DOCNO>NCT01703845</DOCNO>
	<brief_summary>The primary objective study ass pharmacokinetics tiotropium + olodaterol fixed-dose combination ( 2.5 µg/ 5 µg , 5 µg/ 5 µg ) deliver RESPIMAT inhaler 3 week daily treatment Japanese patient COPD .</brief_summary>
	<brief_title>A Study Characterize Pharmacokinetics Tiotropium + Olodaterol Fixed-dose Combination Japanese Patients With COPD .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . Diagnosis chronic obstructive pulmonary disease 2 . Relatively stable airway obstruction post FEV1= &lt; 30 % predict normal &lt; 80 % predict normal post FEV1/FVC &lt; 70 % 3 . Male female Japanese patient , 40 year age old 4 . Smoking history 10 pack year Exclusion criterion : 1 . Significant disease COPD 2 . Clinically relevant abnormal lab value 3 . History asthma 4 . Diagnosis thyrotoxicosis 5 . Diagnosis paroxysmal tachycardia 6 . A marked baseline prolongation QT/QTc interval 7 . A history additional risk factor Torsade de Pointes ( TdP ) 8 . History myocardial infarction within 1 year screen visit 9 . Unstable lifethreatening cardiac arrhythmia 10 . Hospitalization heart failure within past year 11 . Known active tuberculosis 12 . Malignancy patient undergone resection , radiation therapy chemotherapy within last five year 13 . History lifethreatening pulmonary obstruction 14 . History cystic fibrosis 15 . Clinically evident bronchiectasis 16 . History significant alcohol drug abuse 17 . Thoracotomy pulmonary resection 18 . Oral ßadrenergics 19 . Oral corticosteroid medication unstable dose 20 . Regular use daytime oxygen therapy one hour per day 21 . Pulmonary rehabilitation program six week prior screen visit 22 . Investigational drug within one month six half life ( whichever great ) prior screen visit 23 . Known hypersensitivity ßadrenergic drug , anticholinergic , BAC , EDTA 24 . Pregnant nursing woman 25 . Women childbearing potential use highly effective method birth control 26 . Patients previously randomize study currently participate another study 27 . Patients unable comply pulmonary medication restriction 28 . Patients narrowangle glaucoma micturition disorder due prostatic hyperplasia etc 29 . Patients treat medication prolong QT/QTc interval</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>